Skip to content

Clinical trial on effectiveness of Varmam therapy for Otrai thalai vali ( Migraine )

An Open Single-arm, Single-centric Clinical Trial on the therapeutic effectiveness of Varmam Therapy in the management of Otrai Thalai Vali (Migraine) - A pilot study - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057265
Enrollment
20
Registered
2023-09-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

Intervention1: Varmam therapy: Varmam Therapy is done in the specific Varmam points in the head region in weekly thrice basis. The time for each treatment sitting is 5-8 minutes Total duration of the

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: History of five attacks lasting for 4-72 hours in the past 3 months Patients having the symptoms of unilateral headache with pulsating quality, pain with mild to moderate intensity and aggravated by routine physical activity Patients must have any one of the following symptoms, Often accompanied by nausea (and/or vomiting) Photophobia Phonophobia Patient who are willing to involve in the study by signing the consent and fulfilling the condition of performa Patient who has Headache Impact Test total score 36-59 and Migraine Disability Assessment Test score 6-20

Exclusion criteria

Exclusion criteria: K/C/O Cardiovascular disease. K/C/O Trigeminal neuralgia K/C/O Trauma Patients with uncontrolled diabetes mellitus Patients with uncontrolled hypertension K/C/O Psychiatric diseases K/C/O of Seizures K/C/O Eye disease and uncorrected refractive errors K/C/O cervical spondylosis

Design outcomes

Primary

MeasureTime frame
Outcome of the study is mainly assessed by reduction in clinical symptoms through, Headache Impact Test Scale Migraine Disability Assessment Test Scale Headache diary. Timepoint: The outcome is measured 2 weeks once

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr K Vishnu Priya

National Institute of Siddha

mvmresearch2008@gmail.com9840417565

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026